Regulatory Roundup: International Conference on Harmonization Hosts a Series of New Training Sessions - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: International Conference on Harmonization Hosts a Series of New Training Sessions

ePT--the Electronic Newsletter of Pharmaceutical Technology

The International Conference on Harmonization (ICH) is hosting a series of new training sessions this spring. A follow-up training program to the organizations ICH Q8, Q9, and Q10 Quality Implementation program will take place in Japan. The workshop will provide comprehensive information on the integrated quality-trio guidelines and is cosponsored by the Japan Pharmaceutical Manufacturers Association and the Pharmaceutical and Medical Device Regulatory Science Society of Japan.

In related news, the ICH Global Cooperation Group (GCG) endorsed the SADC training for regulators on the ICH Q7 guideline (GMP for APIs). The training is scheduled for this summer in Tanzania. GCC also endorsed ASEAN's request for training regulators and industry on the ICH Q5C guideline (quality of biotechnological products) and that training will take place this spring Kuala Lumpur. Finally, GCC endorsed a request for training on the ICH Q5 series of guidelines (Q5A - Q5E) on quality of biotechnological products, which will take place in spring 2011. Visit the ICH website for further details on these programs.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
42%
No government involvement in patient treatment or drug development.
12%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here